Is It Too Late To Consider Arcellx (ACLX) After Its Recent Share Price Surge? [Yahoo! Finance]
Arcellx, Inc. (ACLX)
Company Research
Source: Yahoo! Finance
If you are trying to work out whether Arcellx at around US$113.76 is still offering value or already pricing in a lot of optimism, you will want to look closely at how different valuation methods line up. The share price moves have been intense, with returns of 64.8% over the last 7 days, 66.0% over 30 days, 79.6% year to date and 88.8% over 1 year, plus a very large 3 year return that points to a stock that has already re rated significantly. These moves sit against a backdrop of fresh interest in Arcellx and its cell therapy pipeline, where recent announcements and clinical updates have kept the company on many biotech watchlists. For investors, that context matters because sentiment around trial progress, partnerships or regulatory milestones can quickly change how the market prices future expectations into the stock. On our simple 6 point valuation framework, Arcellx currently scores a 2 out of 6 . The core of this article will walk through what that means across different
Show less
Read more
Impact Snapshot
Event Time:
ACLX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACLX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACLX alerts
High impacting Arcellx, Inc. news events
Weekly update
A roundup of the hottest topics
ACLX
News
- This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal [Yahoo! Finance]Yahoo! Finance
- Are MASI, ACLX, GLDD Obtaining Fair Deals for their Shareholders?PR Newswire
- Arcellx Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcellx, Inc. - ACLXBusiness Wire
- How Renewed Wall Street Optimism Around HIV, Oncology And IP Runway At Gilead Sciences (GILD) Has Changed Its Investment Story [Yahoo! Finance]Yahoo! Finance
- Gilead Sciences, Inc. (GILD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
ACLX
Earnings
- 2/26/26 - Miss
ACLX
Sec Filings
- 3/6/26 - Form SC
- 3/6/26 - Form SC
- 3/6/26 - Form SCHEDULE
- ACLX's page on the SEC website